AVITA Medical, Inc. (RCEL)

AVITA Medical Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Jun 30, 2021
Cash & Equivalents	9.14	10.24	14.05	22.12	18.16	110.75
Short-Term Investments	2	7.94	21.84	66.94	61.18	-
Cash & Short-Term Investments	11.14	18.19	35.89	89.06	79.34	110.75
Cash Growth	-29.03%	-49.32%	-59.71%	12.24%	-28.36%	50.39%
Accounts Receivable	9.87	9.09	11.79	7.66	3.52	3.47
Other Receivables	-	-	-	0.03	0.9	3.94
Total Trade Receivables	9.87	9.09	11.79	7.69	4.41	7.4
Inventory	5.29	6.93	7.27	5.6	2.13	1.65
Other Current Assets	2.11	1.29	2.06	1.66	1.58	1.33
Total Current Assets	28.39	35.49	57	104.01	87.46	121.33
Net Property, Plant & Equipment	10.33	11.53	13.59	4.32	2.05	2.94
Other Intangible Assets	5.25	5.65	5.57	0.49	0.47	0.47
Long-Term Investments	-	-	-	-	6.93	-
Other Long-Term Assets	3.8	3.73	3.55	2.83	1.36	0.96
Total Assets	47.78	56.39	79.71	111.64	98.26	125.5

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Jun 30, 2021
Accounts Payable	6.42	8.96	6.29	3.79	3	3.12
Accrued Expenses	8.82	7.81	10.45	7.97	6.62	3.32
Short-Term Debt	46.66	42.98	-	-	-	-
Unearned Revenue	0.27	0.29	0.32	0.36	0.7	1.08
Other Current Liabilities	6.81	2.92	3.41	1.43	1.07	0.95
Total Current Liabilities	68.71	62.97	20.48	13.56	11.39	8.47
Long-Term Debt	-	-	42.25	39.81	-	-
Long-Term Leases	1.82	-	-	-	-	-
Other Long-Term Liabilities	4.81	7.94	9.4	6.82	1.27	0.5
Total Long-Term Liabilities	6.63	7.94	51.65	46.63	1.27	0.5
Total Liabilities	75.62	70.91	72.13	60.19	12.66	8.97

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Jun 30, 2021
Common Stock	0	0	0	0	0	0
Treasury Stock	-0.63	-1.29	-1.32	-1.13	-0.13	-
Additional Paid-in Capital	399.54	394.41	367.57	350.04	339.83	328.89
Accumulated Other Comprehensive Income	-0.08	-1.37	-1.94	-1.89	7.63	8.26
Retained Earnings	-426.68	-	-	-	-	-
Total Common Shareholders' Equity	-27.84	391.75	364.31	347.03	347.33	337.15
Minority Interest	-	-	0.24	0.69	0.56	-
Shareholders' Equity	-27.84	391.75	364.56	347.72	347.89	337.15
Total Liabilities & Equity	47.78	56.39	79.71	111.64	98.26	125.5

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Jun 30, 2021
Total Debt	48.48	42.98	42.25	39.81	0	0
Net Cash (Debt)	-37.35	-24.8	-6.36	49.25	79.34	110.75
Net Cash Growth	-	-	-	-37.93%	-28.36%	50.39%
Net Cash Per Share	-24.88	-17.80	-4.91	38.88	63.47	97.68
Book Value	-27.84	391.75	364.31	347.03	347.33	337.15
Book Value Per Share	-18.55	281.22	281.51	273.99	277.86	297.39
Tangible Book Value	-33.09	386.11	358.74	346.54	346.86	336.68
Tangible Book Value Per Share	-22.05	277.17	277.20	273.61	277.49	296.97

SEC Filings: 10-K · 10-Q

Data Source: Fiscal.ai Last updated: Aug 6, 2026

Financial data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 12, 2026

Data Sources Report a data error